ZYXI ZYNEX INC

Nasdaq zynex.com


$ 0.46 $ -0.08 (-14.18 %)    

Thursday, 20-Nov-2025 12:40:09 EST
QQQ $ 591.33 $ -20.34 (-3.33 %)
DIA $ 458.26 $ -8.42 (-1.8 %)
SPY $ 656.51 $ -16.39 (-2.44 %)
TLT $ 89.30 $ 0.32 (0.35 %)
GLD $ 372.63 $ -2.56 (-0.68 %)
$ 0.555
$ 0.54
$ 0.45 x 3,300
$ 0.46 x 200
$ 0.44 - $ 0.57
$ 0.38 - $ 8.72
101,117,305
na
16.87M
$ 1.26
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-17-2025 09-30-2025 10-Q
2 07-31-2025 06-30-2025 10-Q
3 04-29-2025 03-31-2025 10-Q
4 03-11-2025 12-31-2024 10-K
5 10-24-2024 09-30-2024 10-Q
6 07-25-2024 06-30-2024 10-Q
7 04-30-2024 03-31-2024 10-Q
8 03-12-2024 12-31-2023 10-K
9 10-26-2023 09-30-2023 10-Q
10 07-27-2023 06-30-2023 10-Q
11 04-27-2023 03-31-2023 10-Q
12 03-14-2023 12-31-2022 10-K
13 10-27-2022 09-30-2022 10-Q
14 07-28-2022 06-30-2022 10-Q
15 04-28-2022 03-31-2022 10-Q
16 03-21-2022 12-31-2021 10-K
17 11-02-2021 09-30-2021 10-Q
18 07-29-2021 06-30-2021 10-Q
19 04-29-2021 03-31-2021 10-Q
20 02-25-2021 12-31-2020 10-K
21 10-27-2020 09-30-2020 10-Q
22 07-28-2020 06-30-2020 10-Q
23 04-28-2020 03-31-2020 10-Q
24 02-27-2020 12-31-2019 10-K
25 10-29-2019 09-30-2019 10-Q
26 07-31-2019 06-30-2019 10-Q
27 04-30-2019 03-31-2019 10-Q
28 02-26-2019 12-31-2018 10-K
29 11-06-2018 09-30-2018 10-Q
30 08-02-2018 06-30-2018 10-Q
31 05-08-2018 03-31-2018 10-Q
32 02-28-2018 12-31-2017 10-K
33 11-13-2017 09-30-2017 10-Q
34 08-14-2017 06-30-2017 10-Q
35 05-26-2017 03-31-2017 10-Q
36 04-17-2017 12-31-2016 10-K
37 11-14-2016 09-30-2016 10-Q
38 08-23-2016 06-30-2016 10-Q
39 05-20-2016 03-31-2016 10-Q
40 03-31-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 earnings-outlook-for-zynex
Earnings Outlook For Zynex
11/17/2025 16:03:11

 zynex-exploring-alternative-including-potential-capital-raising-recapitalization-and-restructuring

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive m...

 zynex-terminated-positions-of-a-majority-of-zms-employees-to-seek-commercialization-partner-for-nico-co-oximeter-rather-than-pursue-commercialization-independently

https://www.sec.gov/Archives/edgar/data/846475/000110465925097588/zyxi-20251001x8k.htm

 hc-wainwright--co-downgrades-zynex-to-neutral

HC Wainwright & Co. analyst Yi Chen downgrades Zynex (NASDAQ:ZYXI) from Buy to Neutral.

 update-zynex-q2-adj-eps-032-misses-020-estimate-sales-2229m-miss-2738m-estimate

Zynex (NASDAQ:ZYXI) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.20) by 62...

 zynex-dan-moorhead-resigns-as-cfo--effective-august-29-2025

-SEC Filing

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION